TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 3 | 1 | 2 | -12 | 0 | -27 | -7 |
| P | %wins | 50 | 50 | 50 | 0 | 50 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/17/14 16:04 | 9/16/14 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Gur-Lavie Boaz | L3 | O | CFO | P | 3 | 2.75 | 0 | 1 | 2 | 59 | D | -38 | -18 | -31 | -12 | 3 | 1 | -4 | 1 | -1 | -2 | -1 | -15 | -3 | -30 |
9/16/14 16:30 | 9/16/14 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Gur-Lavie Boaz | L3 | O | CFO | P | 10 | 2.84 | 0 | 3 | 6 | 58 | D | -42 | -16 | -32 | -16 | -2 | 2 | -6 | -5 | 6 | 3 | 4 | -8 | 3 | -24 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |